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GRAFT-versus-host disease (GVHO), in which immu-
, nocompetent cells in the graft react against the 
recipient, has been one of the concerns after small bowel 
transplantation. because of the large amount of lympho-
cytes in gut-associated lymphoid tissue (GALT) and mes-
enteric lymph nodes. In rodent experiments. GVHD has 
been extensivelY studied using convenient unidirectional 
transplantation from parent strains to FI hybrids. 1 How-
ever. in fully allogeneic transplantation and large animal 
experiments. rejection and not GVHD has been the dom-
inant phenomenon. We found that smail bowel transplan-
tation from Lewis to Brown Norway rats induced fatal 
GVHD when transient immunosuppression with FK 506 
was employed. similar to the study shown with cyclospo-
rine (CyA).2 
We had previously concentrated on recipient lymphoid 
trafficking after small bowel transplantation and have 
shown that most of the lymphoid tissues in small bowel 
allograft are replaced by the recipient hematolymphoid 
cells.3 In the current study. we focused on the donor 
lymphoid tissues implanted with the graft. 
The fate of the donor lymphoid cells in the recipient and 
its relationship to the development of GVHO was exam-
ined. 
MATERIALS AND METHODS 
Animals 
Inbred malt: Lewis rats (RT-ll, LEW) and Brown Norway rats 
(RT-ln, BN) weighing 200 to 300 g were obtained from Harlan 
Sprague Dawley (Indianapolis. Ind). and were maintained in 
conventional animal facilities under standard conditions. 
Orthotopic Small Intestine Transplantation With 
Portal Drainage 
The entire donor small intestine from the ligament of Treitz to the 
ileocecal valve was isolated on a vascular pedicle consisting of the 
superior mesenteric artery on a segment of aorta and portal vein. 
After the graft was perfused with 10 mL of cold lactated Ringer's 
solution, the lumen was washed with cold neomycin sulfate 
solution. End-to-side vascular anastomoses were performed be· 
twccn the graft aorta and recipient infrarenal aorta and graft portal 
vein and recipient portal vein. The entire recipient small intestine 
was resected. Intestinal continuity was restored by proximal and 
distal intestinal anastomoses. 
FK 506 
Intramuscular (1M) FK 506. dissolved in carrier solvent (HCO-60 
and D-mannitol) (Fujisawa Pharmaceutical Co. Osaka, Japan) was 
diluted in normal saline and injected in the thigh for 14 days 
starting on the day of surgery. ,,' 
Histopathology of GVHD 
Tissues were obtained from the animals showing GVRD. Mesen-
teric lymph nodes and Peyer's patChes from jejunum and ileum 
were obtained from the grafts. Samples of recipient tissues, 
including the liver. splccn, mesenteric lymph nodes, duodenum, 
thymus. lymph node. and skin (ear and tongue) were also taken. 
Tissues were stained with R&E. and L·21-6 (mouse anti-LEW 
class II monoclonal antibody, kindly provided by Dr Yagihashi. 
University of Pittsburgh. Department of Surgery) as described 
previously. J 
Flow Cytometry 
Animals were sacrificed for the dow cytometric analysis 7 days 
after transplantation and when they developed GVHD (LEW to 
BN) to determine the distribution of donor and recipient lympho-
cytes. Lymphocytes were obtained from graft mesenteric lymph 
nodes by gently mincing the tissues in RPMI (Gibco, Grand 
Island. NY). followed by nylon mesh filtering. Lymphocytes from 
Peyer's patches were obtained by isolating the patches. followed 
by vigorous mechanical agitation and filtration similar to above. 
Biotinylated rat monoclonal antibody 163, which is specific for the 
RTl.A1 antigen on LEW, or 42, which is specific for the RT-/.A" 
antigen on BNJ (kindly provided by Dr H. W. Kunz, University of 
Pittsburgh. Department of Pathology) were added to lymphocyte 
suspension for 45 minutes at 4°C. After washing, FITC-conjugated 
streptavidin (Pharmingen. San Diego, Callt) was added for an-
other 10 minutes at 4°C. The samples were analyzed using a 
FACScan flow cytometer. and the percentage of cells stained 
positive with each monoclonal antibody was determined. 
RESULTS 
Animal Survivals 
When BN grafts were transplanted into LEW recipients. 
untreated animals died of rejection with a median survival 
of 10.5 days (Table 1). FK 506 treatment (0.64 mglkg for 14 
days) was effective in prolonging the animal survival to 
more than 100 days. without any signs of GVHO. How-
ever, this short-term treatment has been shown to result in 
chronic-type graft rejection.3 
By contrast, reversing the direction of transplantation 
(LEW to BN) induced fatal GVHD when the same dose 
arid duration of FK 506 was administered. Without any 
treatment, BN recipients rejected LEW grafts within 13 
days. After FK 506 treatment. the BN recipients devel-
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LYMPHOCYTE TRAFFIC AND GVHD 
Table 1. Animal Survival After Small Bowel Transplantation 
SUIVivaJ Median 
Donor Recipient FK506 (d) (d) 
BN LEW None 9,9,10,11,12,14 10.5 
0,64 mglkg x 14 >100 x 9 >100 
LEW BN None 11,12,13 12.0 
0.64 mQlkg x 14 17: 27: 28: 29: 29.0· 
30: 36: 36' 
'Animals died with GVHD. 
oped erythema between 20 and 25 days after transplanta-
tion (6 to 11 days after cessation of FK 506); thereafter. the 
recipients expressed skin erosion. hyperkeratosis. body 
weight loss. and eventual death. with median survival of 
29.0 days. 
Flow Cytometry 
Seven days after transplantation. 70% to 80% of the 
lymphocytes in graft mesenteric lymph nodes were recip-
ient phenotype in both combinations. In BN recipients 
showing clinical GVHD 30 to 35 days after transplantation. 
most of the lymphocytes in the grafts were also recipient 
origin (Table 2). 
Histopathology 
Histologic examination of the skin of BN recipients with 
clinical G VHD revealed apoptosis. basal layer lymphocyte 
infiltration. and vacuolization. similar to the findings seen 
in GVHD after bone marrow transplantation. Phenotypic 
analysis of the dermal infiltrates revealed many donor class 
II-positive (L-21-6+) cells. Donor cells (L-21-6+) were 
also detected in the spleen. mesenteric lymph nodes. and 
thymus in GVHD animals. Donor class II-positive cells in 
the recipient thymus were rare early in the course of 
GVHD. and were largely populated in medulla. The num-
ber of donor cells in the recipient thymus increased as 
GVHD worsened. but remained a relatively small popula-
tion. 
Table 2. Percentages of Donor or Recipient Phenotype 
Lymphocytes In Graft Me.merlc Lymph Nodea 
Donor·Recipient Days after 
CombInation Tranepiantation Donor·Type Recipient· Type 
BN-LEW 7 27.7 :;!: 3.5 69,4 :;!: 1.6 
LEW·BN 7 18.9 ± 2.8 80.4 ± 7.0 
30-35 3.8 ± 2.9 96.2 :;!: 2.8 
(with GVHD) 
Reautts are eXJ)t8SS8d as mean :!: SO (percent 01 positive cells). 
Two to three animals/group were examined. 
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DISCUSSION 
The rapid movement of recipient lymphocytes into the 
graft lymphoid tissue and the migration of the donor 
lymphocytes. which has been considered to cause GVHD. 
into the recipient tissues occurred soon after the transplan-
tation under FK 506. This two-way traffic between the 
graft and recipient was not significantly different in animals 
who developed GVHD. compared to those who did not. 
when examined on day 7 after grafting. When animals 
actually developed GVHD. most of the cells in the small 
bowel allografts were of recipient origin. Donor-phenotype 
cells were found in the spleen. mesenteric lymph nodes. 
and skin of the recipients with GVHD. Donor-type cells 
were found in the thymus only when the GVHD was 
advanced and the thymus was atrophic. Whether extended 
FK 506 treatment can offer sanctuary to donor hematopoi-
etic cells for prolonged periods of time. resulting in de· 
layed emergence of GVHD. is currently under investiga-
tion. 
In the past. the traffic of mature T cells from the thymus 
to the periphery has been considered unidirectional. How-
ever. re-entry of mature activated T cells into the thymus 
has been shown to occur.5 This may explain why donor 
MHC class II-positive cells were seen in the recipients 
only after the animals developed GVHD in this study. The 
significance of matured donor-type cells in the recipient 
thymus after small bowel transplantation is unknown. 
However. it has been shown that mature allogeneic T cells 
enter the recipient thymus after bone marrow transplanta-
tion and may be responsible for the pathogenesis of 
chronic GVHD.6 
This study has shown that the balance between rejection 
and GVHD. after small bowel transplantation. is affected 
by donor and recipient strain combinations and the dosage 
and duration of immunosuppressive therapy. Therefore. 
fully allogeneic transplantation will be more realistic to 
study the rare occurrence of GVHD after small bowel 
transplantation. 
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